Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy

D. G. Bostwick, D. Ramnani, Liang Cheng

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Substantial and characteristic changes occur in the microscopic appearance and immunophenotype of the hyperplastic prostate and adenocarcinoma following androgen deprivation therapy and radiotherapy. These changes are rarely seen in untreated cancer, and in the authors' opinion, the combinations of features following therapy are sufficiently distinctive to warrant recognition. Pathologists must be aware of these distinct changes because of the reliance placed on nuclear and nucleolar size in the identification of prostate cancer, particularly in small specimens and lymph node metastases.

Original languageEnglish (US)
Pages (from-to)465-479
Number of pages15
JournalUrologic Clinics of North America
Volume26
Issue number3
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Prostatic Hyperplasia
Androgens
Prostatic Neoplasms
Radiotherapy
Prostate
Adenocarcinoma
Lymph Nodes
Neoplasm Metastasis
Therapeutics
Neoplasms
Pathologists

ASJC Scopus subject areas

  • Urology

Cite this

Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy. / Bostwick, D. G.; Ramnani, D.; Cheng, Liang.

In: Urologic Clinics of North America, Vol. 26, No. 3, 1999, p. 465-479.

Research output: Contribution to journalArticle

@article{91945e1265b74b92aec6905063e57e44,
title = "Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy",
abstract = "Substantial and characteristic changes occur in the microscopic appearance and immunophenotype of the hyperplastic prostate and adenocarcinoma following androgen deprivation therapy and radiotherapy. These changes are rarely seen in untreated cancer, and in the authors' opinion, the combinations of features following therapy are sufficiently distinctive to warrant recognition. Pathologists must be aware of these distinct changes because of the reliance placed on nuclear and nucleolar size in the identification of prostate cancer, particularly in small specimens and lymph node metastases.",
author = "Bostwick, {D. G.} and D. Ramnani and Liang Cheng",
year = "1999",
doi = "10.1016/S0094-0143(05)70195-6",
language = "English (US)",
volume = "26",
pages = "465--479",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy

AU - Bostwick, D. G.

AU - Ramnani, D.

AU - Cheng, Liang

PY - 1999

Y1 - 1999

N2 - Substantial and characteristic changes occur in the microscopic appearance and immunophenotype of the hyperplastic prostate and adenocarcinoma following androgen deprivation therapy and radiotherapy. These changes are rarely seen in untreated cancer, and in the authors' opinion, the combinations of features following therapy are sufficiently distinctive to warrant recognition. Pathologists must be aware of these distinct changes because of the reliance placed on nuclear and nucleolar size in the identification of prostate cancer, particularly in small specimens and lymph node metastases.

AB - Substantial and characteristic changes occur in the microscopic appearance and immunophenotype of the hyperplastic prostate and adenocarcinoma following androgen deprivation therapy and radiotherapy. These changes are rarely seen in untreated cancer, and in the authors' opinion, the combinations of features following therapy are sufficiently distinctive to warrant recognition. Pathologists must be aware of these distinct changes because of the reliance placed on nuclear and nucleolar size in the identification of prostate cancer, particularly in small specimens and lymph node metastases.

UR - http://www.scopus.com/inward/record.url?scp=0032852009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032852009&partnerID=8YFLogxK

U2 - 10.1016/S0094-0143(05)70195-6

DO - 10.1016/S0094-0143(05)70195-6

M3 - Article

VL - 26

SP - 465

EP - 479

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 3

ER -